Alphatec Holdings, Inc. (ATEC)
USD 10.01
(-1.96%)
USD 10.01
(-1.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 703.48 Million USD | 27.89% |
| 2022 | 550.08 Million USD | 11.66% |
| 2021 | 492.63 Million USD | 275.07% |
| 2020 | 131.34 Million USD | 3.98% |
| 2019 | 126.31 Million USD | 12.88% |
| 2018 | 111.9 Million USD | 0.53% |
| 2017 | 111.31 Million USD | -18.2% |
| 2016 | 136.08 Million USD | -25.75% |
| 2015 | 183.28 Million USD | -6.48% |
| 2014 | 195.96 Million USD | 1.04% |
| 2013 | 193.95 Million USD | 42.29% |
| 2012 | 136.31 Million USD | 12.32% |
| 2011 | 121.36 Million USD | 9.75% |
| 2010 | 110.58 Million USD | 27.02% |
| 2009 | 87.05 Million USD | 3.54% |
| 2008 | 84.07 Million USD | 60.49% |
| 2007 | 52.39 Million USD | 1.62% |
| 2006 | 51.55 Million USD | -59.24% |
| 2005 | 126.48 Million USD | 1234.44% |
| 2004 | 9.47 Million USD | 0.0% |
| 2002 | 5.04 Million USD | -18.17% |
| 2001 | 6.16 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 727.87 Million USD | 2.02% |
| 2024 Q1 | 713.42 Million USD | 1.41% |
| 2024 Q3 | 747.25 Million USD | 2.66% |
| 2023 FY | 703.48 Million USD | 27.89% |
| 2023 Q4 | 703.48 Million USD | -1.52% |
| 2023 Q3 | 714.38 Million USD | 8.84% |
| 2023 Q2 | 656.38 Million USD | 4.51% |
| 2023 Q1 | 628.05 Million USD | 14.17% |
| 2022 Q3 | 538.85 Million USD | 7.47% |
| 2022 Q2 | 501.39 Million USD | -1.05% |
| 2022 Q4 | 550.08 Million USD | 2.09% |
| 2022 FY | 550.08 Million USD | 11.66% |
| 2022 Q1 | 506.7 Million USD | 2.86% |
| 2021 FY | 492.63 Million USD | 275.07% |
| 2021 Q1 | 296.21 Million USD | 125.52% |
| 2021 Q2 | 227.51 Million USD | -23.19% |
| 2021 Q3 | 486.35 Million USD | 113.77% |
| 2021 Q4 | 492.63 Million USD | 1.29% |
| 2020 Q4 | 131.34 Million USD | -10.42% |
| 2020 Q3 | 146.62 Million USD | 3.03% |
| 2020 FY | 131.34 Million USD | 3.98% |
| 2020 Q1 | 126.4 Million USD | 0.07% |
| 2020 Q2 | 142.31 Million USD | 12.58% |
| 2019 Q2 | 119.27 Million USD | 8.26% |
| 2019 FY | 126.31 Million USD | 12.88% |
| 2019 Q4 | 126.31 Million USD | 4.72% |
| 2019 Q3 | 120.62 Million USD | 1.14% |
| 2019 Q1 | 110.16 Million USD | -1.55% |
| 2018 Q3 | 107.25 Million USD | -1.85% |
| 2018 Q2 | 109.27 Million USD | -2.23% |
| 2018 Q1 | 111.76 Million USD | 0.4% |
| 2018 Q4 | 111.9 Million USD | 4.34% |
| 2018 FY | 111.9 Million USD | 0.53% |
| 2017 Q1 | 122.7 Million USD | -9.83% |
| 2017 FY | 111.31 Million USD | -18.2% |
| 2017 Q4 | 111.31 Million USD | -1.74% |
| 2017 Q3 | 113.28 Million USD | -2.12% |
| 2017 Q2 | 115.74 Million USD | -5.67% |
| 2016 Q3 | 134.23 Million USD | -26.57% |
| 2016 Q2 | 182.81 Million USD | -2.62% |
| 2016 Q1 | 187.73 Million USD | 2.43% |
| 2016 FY | 136.08 Million USD | -25.75% |
| 2016 Q4 | 136.08 Million USD | 1.38% |
| 2015 Q3 | 174.53 Million USD | -3.35% |
| 2015 Q1 | 185.66 Million USD | -5.26% |
| 2015 FY | 183.28 Million USD | -6.48% |
| 2015 Q4 | 183.28 Million USD | 5.01% |
| 2015 Q2 | 180.58 Million USD | -2.73% |
| 2014 Q1 | 220.15 Million USD | 13.51% |
| 2014 FY | 195.96 Million USD | 1.04% |
| 2014 Q4 | 195.96 Million USD | 0.35% |
| 2014 Q3 | 195.28 Million USD | -2.78% |
| 2014 Q2 | 200.86 Million USD | -8.76% |
| 2013 Q3 | 137.16 Million USD | 6.5% |
| 2013 FY | 193.95 Million USD | 42.29% |
| 2013 Q2 | 128.78 Million USD | -4.13% |
| 2013 Q1 | 134.33 Million USD | -1.45% |
| 2013 Q4 | 193.95 Million USD | 41.4% |
| 2012 Q3 | 127.61 Million USD | 4.3% |
| 2012 Q4 | 136.31 Million USD | 6.81% |
| 2012 FY | 136.31 Million USD | 12.32% |
| 2012 Q1 | 115.8 Million USD | -4.58% |
| 2012 Q2 | 122.35 Million USD | 5.65% |
| 2011 Q4 | 121.36 Million USD | 15.34% |
| 2011 FY | 121.36 Million USD | 9.75% |
| 2011 Q1 | 113.63 Million USD | 2.76% |
| 2011 Q2 | 109.12 Million USD | -3.97% |
| 2011 Q3 | 105.22 Million USD | -3.57% |
| 2010 Q2 | 116.69 Million USD | -7.86% |
| 2010 FY | 110.58 Million USD | 27.02% |
| 2010 Q1 | 126.65 Million USD | 45.48% |
| 2010 Q4 | 110.58 Million USD | -8.47% |
| 2010 Q3 | 120.81 Million USD | 3.52% |
| 2009 Q1 | 90.7 Million USD | 7.88% |
| 2009 Q4 | 87.05 Million USD | -2.24% |
| 2009 Q3 | 89.05 Million USD | -7.4% |
| 2009 FY | 87.05 Million USD | 3.54% |
| 2009 Q2 | 96.17 Million USD | 6.03% |
| 2008 FY | 84.07 Million USD | 60.49% |
| 2008 Q4 | 84.07 Million USD | 15.53% |
| 2008 Q3 | 72.77 Million USD | 16.09% |
| 2008 Q2 | 62.69 Million USD | -8.34% |
| 2008 Q1 | 68.39 Million USD | 30.54% |
| 2007 Q3 | 51.13 Million USD | 1.24% |
| 2007 FY | 52.39 Million USD | 1.62% |
| 2007 Q1 | 47.59 Million USD | -7.68% |
| 2007 Q2 | 50.51 Million USD | 6.13% |
| 2007 Q4 | 52.39 Million USD | 2.45% |
| 2006 Q1 | 138.16 Million USD | 9.23% |
| 2006 FY | 51.55 Million USD | -59.24% |
| 2006 Q2 | 49.69 Million USD | -64.03% |
| 2006 Q3 | 45.89 Million USD | -7.64% |
| 2006 Q4 | 51.55 Million USD | 12.33% |
| 2005 FY | 126.48 Million USD | 1234.44% |
| 2005 Q4 | 126.48 Million USD | 0.0% |
| 2004 Q4 | 9.47 Million USD | 0.0% |
| 2004 FY | 9.47 Million USD | 0.0% |
| 2002 FY | 5.04 Million USD | -18.17% |
| 2001 FY | 6.16 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -1272.554% |
| BrainsWay Ltd. | 15.31 Million USD | -4493.764% |
| Cerus Corporation | 144.3 Million USD | -387.505% |
| Envoy Medical, Inc. | 9.4 Million USD | -7382.334% |
| electroCore, Inc. | 8.94 Million USD | -7764.606% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -13069.019% |
| IceCure Medical Ltd | 4.24 Million USD | -16464.375% |
| Inogen, Inc. | 121.38 Million USD | -479.566% |
| OrthoPediatrics Corp. | 72.56 Million USD | -869.514% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -2278.179% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -22008.787% |
| MaxCyte, Inc. | 36.1 Million USD | -1848.345% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -37969.441% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -165317.453% |
| Orthofix Medical Inc. | 326.58 Million USD | -115.408% |
| PAVmed Inc | 57.13 Million USD | -1131.232% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -2662.789% |
| RxSight, Inc. | 22.18 Million USD | -3070.583% |
| Sight Sciences, Inc. | 46.43 Million USD | -1414.965% |
| SI-BONE, Inc. | 61.05 Million USD | -1052.316% |
| TELA Bio, Inc. | 59.16 Million USD | -1088.989% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -517.263% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -6717.414% |
| Acutus Medical, Inc. | 54.83 Million USD | -1182.826% |
| Talis Biomedical Corporation | 29.22 Million USD | -2307.23% |
| Spectral AI, Inc. | 12.4 Million USD | -5572.841% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -2940.931% |
| CVRx, Inc. | 39.28 Million USD | -1690.869% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -5782.96% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -28858.507% |
| Bioventus Inc. | 589.79 Million USD | -19.277% |
| Venus Concept Inc. | 107.1 Million USD | -556.834% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -1261.688% |
| LivaNova PLC | 1.15 Billion USD | 38.93% |
| 908 Devices Inc. | 37.49 Million USD | -1776.471% |
| Nemaura Medical Inc. | 26.37 Million USD | -2567.011% |
| NeuroPace, Inc. | 86.99 Million USD | -708.636% |
| LENSAR, Inc. | 22.4 Million USD | -3039.315% |
| Apyx Medical Corporation | 52.31 Million USD | -1244.64% |
| Cutera, Inc. | 518.12 Million USD | -35.777% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -2298.694% |
| BioSig Technologies, Inc. | 4.68 Million USD | -14915.774% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -1105.286% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -3173.869% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 67.937% |
| Axonics, Inc. | 82.35 Million USD | -754.174% |
| Outset Medical, Inc. | 190.91 Million USD | -268.483% |
| IRIDEX Corporation | 24.91 Million USD | -2723.669% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -467.49% |
| IRadimed Corporation | 20.73 Million USD | -3292.608% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -41924.432% |
| INVO Bioscience, Inc. | 19.99 Million USD | -3418.331% |
| Telesis Bio, Inc. | 40.87 Million USD | -1621.158% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -1624.651% |
| Varex Imaging Corporation | 668.6 Million USD | -5.218% |
| Quipt Home Medical Corp. | 136.29 Million USD | -416.159% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -19594.541% |
| Pulmonx Corporation | 60.63 Million USD | -1060.184% |
| Dynatronics Corporation | 11.78 Million USD | -5871.835% |
| Modular Medical, Inc. | 2.27 Million USD | -30863.424% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -17210.261% |
| Semler Scientific, Inc. | 6.27 Million USD | -11119.92% |
| InMode Ltd. | 75.91 Million USD | -826.692% |
| Bruker Corporation | 2.83 Billion USD | 75.2% |
| Cytosorbents Corporation | 29.98 Million USD | -2246.1% |
| DexCom, Inc. | 4.19 Billion USD | 83.234% |
| Align Technology, Inc. | 2.45 Billion USD | 71.326% |
| Viveve Medical, Inc. | 10.84 Million USD | -6385.563% |
| ZimVie Inc. | 795.85 Million USD | 11.606% |
| Movano Inc. | 5.97 Million USD | -11679.789% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -572.519% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -165317.453% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -5782.96% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -10.088% |
| Profound Medical Corp. | 12.66 Million USD | -5454.212% |
| Insulet Corporation | 1.85 Billion USD | 62.086% |
| enVVeno Medical Corporation | 2.43 Million USD | -28790.719% |
| Surmodics, Inc. | 65.82 Million USD | -968.759% |
| iCAD, Inc. | 8 Million USD | -8692.515% |
| Nuwellis, Inc. | 6.78 Million USD | -10275.944% |
| Biotricity, Inc. | 35.91 Million USD | -1858.519% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -215.399% |
| Aethlon Medical, Inc. | 2.47 Million USD | -28270.496% |
| InspireMD, Inc. | 8.14 Million USD | -8540.249% |
| PAVmed Inc. | 57.13 Million USD | -1131.232% |
| BIOLASE, Inc. | 35.34 Million USD | -1890.18% |
| Beyond Air, Inc. | 29.77 Million USD | -2262.683% |
| FONAR Corporation | 57.45 Million USD | -1124.362% |
| AxoGen, Inc. | 101.16 Million USD | -595.408% |
| Vivani Medical, Inc. | 25.03 Million USD | -2709.91% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -701.277% |
| Inari Medical, Inc. | 209.32 Million USD | -236.075% |
| UFP Technologies, Inc. | 118.04 Million USD | -495.95% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -5443.433% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -32084.332% |
| Tenon Medical, Inc. | 5.56 Million USD | -12536.77% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -39444.07% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -3889.364% |
| AdaptHealth Corp. | 3.15 Billion USD | 77.689% |
| Sintx Technologies, Inc. | 6.59 Million USD | -10570.241% |
| NanoVibronix, Inc. | 2.68 Million USD | -26090.953% |
| Quanterix Corporation | 78.08 Million USD | -800.939% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -19594.541% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -14301.003% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 32.662% |
| TransMedics Group, Inc. | 568.84 Million USD | -23.67% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -4117.054% |
| NeuroMetrix, Inc. | 1.33 Million USD | -52669.96% |
| Hyperfine, Inc. | 9.8 Million USD | -7078.459% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -181.119% |
| Biomerica, Inc. | 2.66 Million USD | -26317.161% |
| Bone Biologics Corporation | 831.4 Thousand USD | -84514.783% |
| AVITA Medical, Inc. | 19.86 Million USD | -3441.277% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -35543.465% |
| Silk Road Medical, Inc | 114.15 Million USD | -516.242% |